Oh I see old sport. You’ve gone back to the July 2021 update....

Oh I see old sport. You’ve gone back to the July 2021 update. Well, things have moved on quite a lot since then. Heady days back then. The devotees remember the $2 share price with a tear in their eye.

But the August 2021 update is a bit more salient. That’s where the “operational highlights “ set out the FDA requirement for more trials. Oh, but not before they fix the quality control problems which still remain a problem after spending $10 million. And god knows how long it will take, assuming they can actually fix it.

So, old chum, that’s why it will be 18 months at best. And best never happens in this game. And that’s also why I have previously stated any approval is further away now than it was a year ago. And that’s why the market has knocked another $0.40 off the $2 share price.

It is quite remarkable that the devotees think just because they chug the Koolaid like someone dying a thirst, that everyone else isn’t too.